Skip to main content

Table 5 PR of screening non-participation by multimorbidity ≤2 years and >2–10 years before screening (n = 144,264)

From: Non-participation in breast cancer screening for women with chronic diseases and multimorbidity: a population-based cohort study

 

Unadjusted

Model 1a

Model 2b

 

≤2 years

>2–10 years

≤2 years

>2–10 years

≤2 years

>2–10 years

 

PR (95 % CI)

PR (95 % CI)

PR (95 % CI)

PR (95 % CI)

PR (95 % CI)

PR (95 % CI)

Disease count

      

 0

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 1

1.36 (1.32–1.40)

1.25 (1.22–1.28)

1.25 (1.21–1.29)

1.14 (1.11–1.18)

1.20 (1.16–1.24)

1.08 (1.04–1.11)

 2

1.80 (1.68–1.39)

1.60 (1.52–1.69)

1.55 (1.45–1.67)

1.38 (1.31–1.45)

1.47 (1.36–1.58)

1.25 (1.18–1.32)

  ≥ 3

2.08 (1.68–2.57)

1.87 (1.65–2.12)

1.69 (1.36–2.09)

1.52 (1.33–1.73)

1.58 (1.27–1.96)

1.33 (1.17–1.52)

Multimorbidity (≥2 diseases)

    

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

1.77 (1.65–1.89)

1.58 (1.51–1.66)

1.52 (1.42–1.63)

1.36 (1.30–1.43)

1.38 (1.29–1.49)

1.28 (1.22–1.35)

Severe multimorbidity (≥3 diseases)

    

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

2.00 (1.62–2.48)

1.79 (1.58–2.03)

1.63 (1.31–2.02)

1.47 (1.29–1.67)

1.53 (1.23–1.90)

1.44 (1.26–1.64)

Physical multimorbidity

     

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

1.69 (1.56–1.82)

1.49 (1.40–1.58)

1.47 (1.36–1.59)

1.30 (1.23–1.38)

1.37 (1.26–1.49)

1.23 (1.16–1.31)

Physical-mental multimorbidity

    

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

2.20 (1.94–2.49)

1.88 (1.73–2.04)

1.80 (1.60–2.02)

1.52 (1.40–1.66)

1.54 (1.36–1.75)

1.42 (1.30–1.56)

  1. aAdjusted for age, ethnicity, marital status and education
  2. bAdjusted for age, ethnicity, marital status, education, and for being registered in the NPR or PCRR with the studied multimorbidity in the other time period (yes/no). E.g. severe multimorbidity 0–2 year is adjusted for SEP, and for being in hospital contact with 3 or more chronic disease groups >2-10 years before screening
  3. Statistically significant results in bold